Production of neuropeptides by inflammatory cells within the granulomas of murine Schistosomiasis mansoni

European Journal of Clinical Investigation

Volumn 21, Issue 2, 1991, Pages 145-153

  WEINSTOCK, J V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; GRANULOMA; INFLAMMATORY CELL; MOUSE; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMAL; EOSINOPHILS; GRANULOMA; HUMAN; LYMPHOCYTES; MACROPHAGES; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; RNA, MESSENGER; SCHISTOSOMIASIS MANSONI; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025847353     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1991.tb01803.x     Document Type: Review

References (126)

1. Neuropeptide regulation of immediate and delayed hypersensitivity
2. Immunoregulatory properties of neuroendocrine peptide hormones
3. Method for isolating schistosome granulomas from mouse liver
4. Heterogeneity of the granulomatous response in the liver, colon, ileum, and ileal Peyer's patches to schistosome eggs in murine schistosomiasis mansoni
5. Tachykinin production by granuloma eosinophils in murine schistosomiasis mansoni
6. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P
7. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils
8. Tissue‐specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing
9. Sequence analysis of cloned cDNA for rat substance P precursor: existence of a third substance P precursor
10. cDNA sequence of human B‐preprotachykinin, the common precursor to substance P and neurokinin A
11. Three rat preprotachykinin mRNAs encode the neuropeptide substance P and neurokinin A
12. Release of substance. P by granuloma eosinophils in response to histamine in murine schistosomiasis mansoni
13. Substance P recognitition by a subset of human T lymphocytes
14. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells
15. Substance P: Binding properties and studies on cellular responses in guinea pig macrophages
16. Stereospecific receptors for substance P on cultured human IM‐9 lymphoblasts
17. Specific stimulation of human T lymphocytes by substance P
18. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen
19. Substance P enhances interferon‐γ production by human peripheral blood mononuclear cells
20. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil
21. Tachykinin: effects on motility and metabolism of rat polymorphonuclear leukocytes
22. Substance P induces chemotaxis of neutrophils in normal and capsaicin‐treated rats
23. Enhancement of phagocytosis—a newly found activity of substance P residing‐in its N‐terminal tetrapeptide sequence
24. Release of histamine from mast cells by vasoactive peptides
25. Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release
26. Flare arid itch induced by substance P in human skin
27. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis
28. Intraneuronal substance P contributes to the severity of experimental arthritis
29. Detection of vasoactive intestinal peptide and localization of its mRNA within granulomas of murine schistosomiasis
30. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators
31. Interaction of vasoactive intestinal peptide with human blood mononuclear cells
32. Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells
33. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt‐4b T lymphoblasts
34. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses
35. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage
36. 3
37. Homologous regulation of adenylate cyclase‐coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leukocytes
38. Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase
39. Cyclic AMP‐dependent protein kinase in MOLT 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI)
40. Variable stimulation of adenylate cyclase activity by vasoactive intestinal‐like peptides and B‐adrenergic agonists in murine T cell lymphomas of immature, helper and cytotoxic types
41. Interleukin 5 is required for blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni
42. In vitro alterations of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells
43. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release
44. The effect of vasoactive intestinal peptide on human natural killer cell function
45. Structure and evolution of somatostatin genes
46. Endogenous somatostatin‐like peptides of rat basophilic leukemia cells
47. Vasoactive intestinal polypeptide and somatostatin in leucocytes
48. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon
49. Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes
50. The murine IgA‐secreting plasmacytoma MOPC‐315 expresses somatostatin receptors
51. Distinct subsets of somatostatin receptors on cultured human lymphocytes
52. Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro
53. Immunomodulatory action of somatostatin
54. Modulating effect of beta‐endorphin somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel‐allergic patients to nickel sulfate
55. Inhibition by somatostatin of the proliferation of T‐lymphocytes and Molt‐4 lymphoblasts
56. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils
57. Somatostatin induces histamine secretion from rat peritoneal mast cells
58. Activation of macrophages by neuropeptides
59. Neuropeptide modulating macrophage function
60. Modulation of macrophage‐mediated tumoricidal activity by neuropeptides and neurohormones
61. Human monocyte chemotaxis to neuropeptides
62. Neurotensin enhances IL‐1 production by activated alveolar macrophages
63. Substance P augmentation of CSF‐1 stimulated in vitro myelopoiesis
64. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
65. Substance P, neurokinin A, and neurokinin B induce generation of IL‐1‐like activity in P388D1 cells. Possible relevance to arthritic disease
66. The mechanism of antibody‐dependent cellular cytotoxicity stimulation by somatostatin in rat peritoneal macrophages
67. Enhanced phagocytosis by neurotensin, a newly found biological activity of the neuropeptide
68. Isolated liver granulomas of murine Schistosoma mansoni contain components of the angiotensin system
69. Synthesis of angiotensins by cultured granuloma macrophages in murine schistosomiasis mansoni
70. Granuloma macrophages in murine Schistosoma mansoni generate components of the angiotensin system
71. Enhanced angiotensin II formation in plasma upon exposure to schistosome ova
72. Granulocyte‐angiotensin system. Identification of angiotensinogen as substrate of leukocyte cathepsin G
73. The significance of angiotensin I converting enzyme in granulomatous inflammation
74. Angiotensin‐convertingenzyme:new concepts concerning its biological role
75. The angiotensin cascade in granulomatous inflammation
76. Functional angiotensin II receptors on macrophages from isolated liver granulomas of murine schistosomiasis mansoni
77. Chemotactic response of splenic mononuclear cells to angiotensin II in murine schistosomiasis
78. Binding sites of angiotensin II in human mononuclear leukocytes
79. Analysis of angiotensin II binding to human platelets: differences in young and old subjects
80. Effect of angiotensin II on macrophage functions
81. Angiotensin II stimulation of granuloma macrophage phagocytosis and actin polymerization in murine Schistosoma mansoni
82. The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II
83. Angiotensin II is chemotactic for a T cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni
84. Potentiation of adrenaline‐induced platelet aggregation by angiotensin II
85. Components of the angiotensin system cause release of a neutrophil chemo‐attractant from cultured bovine and human endothelial cells
86. Increased angiotensin‐converting enzyme in peripheral blood monocytes from patients with sarcoidosis
87. Identification of renin in resident alveolar macrophages and monocytes: HPLC and immunohistochemical study
88. Evidence for the presence of angiotensins in normal, unstimulated alveolar macrophages and monocytes
89. Increased colonic mucosal angiotensin I and II concentration in Crohn's colitis
90. Human lymphocyte production of corticotropin and endorphin‐like substances: association with leucocyte interferon
91. Bacterial lipopolysaccharide induction of leucocyte‐derived corticotropin and endorphins
92. Corticotropin releasing factor induction of leucocyte‐derived immunoreactive ACTH and endorphins
93. Human lymphocytes produce pro‐opiomelanocortin gene‐related transcripts
94. Expression of pro‐opiomelanocortin gene and quantification of adrenocorticotropic hormone‐like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies
95. B endorphin secretion by human peripheral blood mononuclear cells: regulation by glucocorticoids
96. Immunoreactive B‐endorphin in a subpopulation of mouse spleen macrophages
97. Pro‐opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages
98. Newcastle disease virus‐infected splenocytes express the proopiomelanocortin gene
99. Proenkephalin A‐like mRNA in human leukemia leukocytes and CNS‐tissues
100. Mitogenic activation of the human lymphocytes induce the release of proenkephalin derived peptides
101. Proenkephalin system in human polymorphonuclear cells. Production and release of a novel 1 0‐KD peptide derived from synenkephalin
102. Regulated expression of proenkephalin A in normal lymphocytes
103. Activation of mouse T‐helper cells induces abundant preproenkephalin mRNA synthesis
104. Human lymphocyte production of immunoreactive thyrotropin
105. Thyrotropin: An endogenous regulator of the in vitro immune response
106. Production of immunoreactive growth hormone by mononuclear leukocytes
107. Bombesin in human and guinea pig macrophages
108. Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice
109. Release of immunoreactive neuropeptide Y by rat platelets
110. Enhanced granuloma angiotensin I converting enzyme activity associated with modulation in murine schistosomiasis
111. Angiotensin‐I‐converting enzyme activity of murine macrophages isolated from granulomas elicited by eggs of Schistosoma mansoni.
112. Alteration of granuloma angiotensin I converting enzyme activity by regulatory T lymphocytes in murine schistosomiasis
113. The effect of SQ 14225, an inhibitor of angiotensin I converting enzyme, on the granulomatous response of Schistosoma mansoni eggs in mice
114. Alteration of the granulomatous response in murine schistosomiasis by the chronic administration of Captopril, an inhibitor of angiotensin I converting enzyme
115. Role of angiotensin‐converting enzyme in Bacille‐Calmett‐Guerin‐induced granulomatous inflammation. Increased angiotensin‐converting enzyme levels in lung lavage and suppression of inflammation with captopril